Project Grant NY2022052
- This $290.8 million project grant from the Department of Transportation's Federal Transit Formula Grants program (CFDA 20.507) will fund capital improvements and accessibility upgrades for the Metropolitan Transportation Authority's New York City Transit and Long Island Rail Road systems. Specifically, the grant will support four projects: replacing components to achieve ADA compliance on the 137th Street subway line; a small business mentoring program and parking rehabilitation for LIRR; and...
- The Metropolitan Transportation Authority (MTA) was awarded a $743.2 million project grant from the Federal Transit Administration's Federal Transit Formula Grants program (CFDA 20.507) on August 18, 2021 to support capital investments in MTA assets and infrastructure through April 30, 2030. Under the award, the MTA will invest funding to rehabilitate and replace assets maintained by New York City Transit, Long Island Rail Road, and Metro-North to achieve and maintain a state of good repair....
- This $307.8 million project grant from the Department of Transportation's Federal Transit Administration through the Federal Transit Formula Grants program (CFDA 20.507) will fund capital improvements to the New York City transit system managed by the Metropolitan Transportation Authority. The grant provides $30.8 million in Section 5307 funds and $6.2 million in Transportation Development Credits for match. Funds will support five projects, including station circulation enhancements on the...
- This $7.2 million Project Grant from the Department of Transportation's Federal Transit Administration, under the Federal Transit Formula Grants program (CFDA 20.507), will fund capital investments by the Metropolitan Transportation Authority to maintain rail infrastructure assets in a state of good repair. Specifically, $500,000 in Congestion Mitigation and Air Quality funds and $3.1 million in Surface Transportation Program funds will support the Long Island Rail Road Transit Tech Project...
- This $88.2 million project grant from the Department of Transportation's Federal Transit Administration, under the Federal Transit Formula Grants (CFDA 20.507) program, will fund accessibility improvements at selected New York City Transit stations. The Metropolitan Transportation Authority will use $17.6 million in transportation development credits and $5.57 million in local match funding to support two specific New York City Transit projects: ADA upgrades at the Woodhaven Boulevard Jamaica...
- The Department of Transportation Federal Transit Administration awarded the Metropolitan Transportation Authority a $471,097,426 project grant under the Federal Transit Formula Grants (CFDA 20.507) program on September 13, 2022. The grant funds capital investments to replace aging infrastructure and improve safety at New York City Transit, including 19 elevators, switchgear at six subway stations, and the Jamaica Yard subway station power system. The grant utilizes $47,109,743 in...
- This $302,756,580 Formula Grant award from the Federal Transit Administration's State of Good Repair Grants Program (CFDA 20.525) will assist the Metropolitan Transportation Authority (MTA) in New York to invest capital funding into its transit assets and infrastructure operated by the New York City Transit (NYCT) and Long Island Rail Road (LIRR) systems. The activities under this grant include state of good repair projects to rehabilitate and replace assets across the MTA's rail and bus...
- This $50,000,000 Formula Grant award from the U.S. Department of Transportation Federal Transit Administration (CFDA 20.507 - Federal Transit Formula Grants) will assist the Metropolitan Transportation Authority (MTA) in New York to invest capital funding into its transit assets and infrastructure maintained by New York City Transit (NYCT). The primary activities performed under this award include an Americans with Disabilities Act (ADA) accessibility project for NYCT. The expected outcomes...
- Federal Grant Award Summary The Metropolitan Transportation Authority (MTA) received a $55 million Formula Grant from the Federal Transit Administration (FTA) under the Federal Transit Formula Grants program (CFDA 20.507), awarded on March 25, 2026, with a completion date of June 30, 2031. This award supports capital investment in Americans with Disabilities Act (ADA) accessibility improvements at New York City Transit (NYCT) stations, specifically funding the installation of elevators,...
- The Metropolitan Transportation Authority (MTA) was awarded a $179,856,525 Project Grant from the United States Department of Transportation Federal Transit Administration under the Federal Transit Formula Grants program (CFDA 20.507) on June 15, 2021. The grant will fund capital and operating assistance projects and transportation planning activities for the MTA's transit systems in New York through September 30, 2026. As the designated recipient for urbanized area formula funds, the MTA will...
This $481.6 million project grant from the Department of Transportation's Federal Transit Formula Grants program (CFDA 20.507) will fund capital investments and accessibility projects for the Metropolitan Transportation Authority's New York City Transit and Long Island Rail Road systems. The grant funds will support track and switch rehabilitation, interlocking expansion, station and yard renovations, and installation of new elevators to improve accessibility. Specific projects include mainline track and switch rehabilitation, expansion of the Hall Interlocking to increase capacity, loading dock exhaust and HVAC upgrades at maintenance shops, accessibility upgrades at stations, and new elevators. The grant utilizes $48.2 million in transportation development credits for local match. Funds will come from Fiscal Year 2021 and 2022 allocations and support the MTA's state of good repair initiatives and ridership. The period of performance is September 14, 2022 through March 31, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $240.8m | 9/14/22 | ||
| Not listed | $240.8m | 9/14/22 |